Readystate Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,120	Closed	-$351K	–	339
2023 Q3	$351K	Buy	+3,120	New	+$351K	0.02%	182